Related Experiment Video
Updated: Jul 13, 2026
10:03
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Left ventricular hypertrophy in renal failure a review
1Department ofMedicine, Federal Medical Center, Owerri.
Nigerian Journal of Clinical Practice
|August 3, 2007
Summary
Left ventricular hypertrophy is a common complication in end-stage renal failure patients undergoing dialysis. This review covers its occurrence, causes, significance, and management strategies for chronic kidney disease.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Renal failure is a growing global health concern.
- Dialysis and transplantation extend the lives of patients with end-stage renal failure.
- Cardiovascular complications, particularly left ventricular hypertrophy, are prevalent in this population.
Purpose of the Study:
- To review the incidence, pathophysiology, clinical significance, evaluation, and management of left ventricular hypertrophy in end-stage renal failure.
- To provide a comprehensive overview for clinicians managing patients with chronic kidney disease and cardiovascular risks.
Main Methods:
- Literature review of studies on left ventricular hypertrophy in renal failure patients.
- Synthesis of information on the epidemiology, mechanisms, clinical impact, diagnostic methods, and treatment options.
Main Results:
- Left ventricular hypertrophy is a frequent complication in patients with end-stage renal failure.
- It is a significant independent predictor of mortality in chronic kidney disease.
- Various factors contribute to its development, including fluid overload, anemia, and hormonal changes.
Conclusions:
- Left ventricular hypertrophy poses a substantial threat to patients with end-stage renal failure.
- Effective management strategies are crucial for improving patient outcomes.
- Further research into targeted interventions is warranted.
More Related Videos
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.